Freenome Raises $254 Million Down Round
Freenome, a Prime Unicorn Index component once valued at $2.6 billion, recently raised a $254 million Series F down round. Freenome is a biotechnology company specializing in developing blood tests for early cancer detection. Using artificial intelligence and advanced genomics, Freenome aims to identify cancerous cells in the bloodstream early, potentially improving treatment outcomes and […]